Retatrutide: The Triple-Hormone GLP-1 That May Beat Semaglutide & Tirzepatide
Retatrutide is the next-generation GLP-1 medication targeting three hormones. Learn how this triple agonist works, trial results, expected approval timeline, and how it compares to semaglutide and tirzepatide.